This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Names Seeing Bullish Flow

TheStreet Premium Services

A complimentary preview
of Options-Profits Previews

WEBINAR: Stocks to Watch and Trade Ideas 12/18 at 6pm ET CLICK HERE FOR INVITE AND TO REGISTER.

Cypress Semiconductor (CY): Early call buying in CY on Thursday has call volume over 5000 contracts which is well above the average full-day volume of 850 contracts. In the money March 10 calls are the focus, with a buyer paying $1.375 for 4600 on the PHLX when shares were at $10.95.

Allscripts Healthcare Solutions (MDRX): Nearly 20,000 calls on MDRX have traded in the first 30 minutes of the day, with a customer paying $0.10 to roll 10,000 December 11 calls out to March 13s on NYSE-Arca, showing a commitment to a longer-term bullish bet into the spring.

United Continental Holdings (UAL): Shares are up 5% near $22.51 and seeing action in the March 23 calls as well as the Jun 25 calls. Thirty day at the money IV of 37% is near the low end of this year's range and airline shares have been gaining altitude in recent days, boosted by Monday's announcement of a deal between Delta Air Lines (DAL) and Virgin Atlantic.

 
UAL Options Dashboard
Source: Trade Alert

 



Hewlett Packard (HPQ): The December 15 calls are very active today, with nearly 24000 contracts trading in the $0.19 range and much of the flow marked an opening buyer, despite the 17,000 of open interest at the strike. HPQ shares have been on a steady climb from post-earnings lows near $11.70 on November 20th.

 
HPQ Daily Contract Volume
Source: Trade Alert



J.C. Penney (JCP): It is not clear if it's Christmas shoppers or some other catalyst, but JCP shares are up 3.6% and call volume in the retailer is very strong. There were 16,000 contracts trading in the first hour, three times the normal volume. January 20 and December 21s lead the most actives, while the December 20 straddle is also busy, and trading near 4% of the share price, despite only having nine days left to trade it.

OptionsProfits can be followed on Twitter at twitter.com/OptionsProfits.

 

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

At the time of publication, Henry Schwartz held no positions in the stocks or issues mentioned.


Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
Top Rated Stocks Top Rated Funds Top Rated ETFs